MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.sapharm.2026.07.011

Медицинская библиотека · Research in social & administrative pharmacy : RSAP · 2026

The prevalence and impact of medication-related harm in people living with dementia - a systematic review and meta-analysis.

Carabine Fiona, Hughes Carmel M, Barry Heather E

СтатьяСистематический обзорМетаанализПеревод пока не подготовлен

Аннотация

OBJECTIVE

People living with dementia (PLWD) take more medications than those without dementia, increasing their risk of medication-related harm, defined as any negative outcome related to medication use, encompassing both harm events and outcomes. This systematic review aimed to determine the prevalence of medication-related harm in PLWD and evaluate its impact across a range of outcomes.

METHODS

Twelve databases were searched from inception to April 2025. Studies of any design reporting the prevalence and/or outcomes of medication-related harm in PLWD were included. Study quality was assessed using appropriate risk of bias tools. A meta-analysis was conducted to determine combined hazard ratios (HRs) and 95% confidence intervals (CIs).

RESULTS

In total, 115 studies were included (110 observational, five randomised controlled trials). Most studies (n = 73) were at low risk of bias. Adverse drug events were the most commonly reported harm event (n = 92), with prevalence ranging from 2.5 to 93.0%. Adverse health outcomes were measured in 55 studies, with 32 reporting increased risk associated with medication use. Psychoactive medications were frequently implicated (n = 59 studies), with 43 reporting a link with negative outcomes. Six studies (n = 25,715 participants) were included in an exploratory meta-analysis, which suggested an association between antipsychotic use and increased mortality (HR = 1.42; 95% CI = 1.10-1.84; p = 0.008).

CONCLUSIONS

This review provides a comprehensive synthesis of medication-related harm in PLWD, highlighting its breadth and complexity across care settings and medication classes. The findings support the need for improved medicines optimisation strategies, including medication review and deprescribing approaches, to reduce harm in this vulnerable population.

Для цитирования: Carabine Fiona, Hughes Carmel M, Barry Heather E. The prevalence and impact of medication-related harm in people living with dementia - a systematic review and meta-analysis.. Research in social & administrative pharmacy : RSAP. 2026. DOI: 10.1016/j.sapharm.2026.07.011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.